Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma

Yong Yu1, Kolja Schleich2, Bin Yue2

  • 1Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, 13125 Berlin, Germany.

Cancer Cell
|February 14, 2018
PubMed

Insights

Histone demethylases like LSD1 and JMJD2C disable cancer cell senescence, promoting melanoma. Inhibiting these enzymes restores senescence, even in resistant melanomas, and controls tumor growth.

Area of Science:

  • Molecular Biology
  • Oncology
  • Epigenetics

Background:

  • Oncogene-induced senescence halts pre-malignant cell proliferation via histone modifications.
  • Repressive trimethylated histone H3 lysine 9 (H3K9) marks silence proliferation genes in senescence.

Purpose of the Study:

  • To investigate the role of H3K9 demethylases in disabling senescence and promoting melanoma.
  • To evaluate the therapeutic potential of targeting H3K9 demethylases in melanoma.

Main Methods:

  • Utilized mouse and zebrafish models with enforced expression of LSD1 or JMJD2C.
  • Analyzed melanoma cell lines and human melanoma samples for H3K9 demethylase activity.
  • Assessed the effects of targeted H3K9 demethylase inhibition on senescence, immune response, and tumor growth in vivo.

Main Results:

  • Enforced expression of LSD1 or JMJD2C promoted Braf-V600E-driven melanomagenesis.
  • Upregulated H3K9 demethylase activities were observed in a significant portion of melanoma samples.
  • Targeted inhibition of H3K9 demethylases restored senescence, including in Braf inhibitor-resistant melanomas.
  • Inhibition also evoked secondary immune effects and controlled tumor growth.

Conclusions:

  • H3K9 demethylases (LSD1, JMJD2C) are key drivers in disabling oncogene-induced senescence, facilitating melanoma development.
  • Targeting these demethylases represents a promising therapeutic strategy for melanoma, overcoming resistance and engaging the immune system.

Related Concept Videos

Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

Transcriptional regulators bind to specific cis-regulatory sequences in the DNA to regulate gene transcription. These cis-regulatory sequences are very short, usually less than ten nucleotide pairs in length. The short length means that there is a high probability of the exact same sequence randomly occurring throughout the genome.  Since regulators can also bind to groups of similar sequences, this further increases the chances of random binding. Transcriptional regulators form...
7.4K
Cooperative Binding of Transcription Regulators02:13

Cooperative Binding of Transcription Regulators

2.6K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.9K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

3.1K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

2.7K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.4K